|
G |
Lep |
leptin |
|
IMP |
|
RGD |
PMID:21328617 |
RGD:5128513 |
NCBI chr 4:58,626,529...58,640,663
|
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IEP |
associated with hepatocellular carcinoma |
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chr 1:181,026,606...181,044,859
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
|
IEP |
associated with hepatocellular carcinoma |
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chr12:34,072,710...34,122,142
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
associated with gastrointestinal system cancer;mRNA,protein:increased expression:subcutaneous adipose tissue: |
RGD |
PMID:21245862 |
RGD:153350145 |
NCBI chr12:16,930,990...16,939,333
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
|
IEP |
associated with Carcinoma, Hepatocellular;protein:increased expression:skeletal muscle |
RGD |
PMID:16685375 |
RGD:2315732 |
NCBI chr 9:80,069,960...80,144,167
|
|
G |
Cd27 |
CD27 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17878525 |
|
NCBI chr 4:158,030,700...158,035,862
|
|
G |
Cdh6 |
cadherin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17878525 |
|
NCBI chr 2:62,079,139...62,225,298
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
treatment |
ISO |
|
RGD |
PMID:27122162 |
RGD:40903021 |
NCBI chr 3:176,817,005...176,818,436
|
|
G |
Coq7 |
coenzyme Q7, hydroxylase |
susceptibility |
ISO |
|
RGD |
PMID:23166727 |
RGD:10402105 |
NCBI chr 1:172,836,359...172,851,173
|
|
G |
Ddx42 |
DEAD-box helicase 42 |
|
IEP ISO |
associated with Diabetes Mellitus, Experimental;mRNA:increased expression:gastrocnemius muscle (rat) associated with Malnutrition;mRNA:increased expression:gastrocnemius muscle (mouse) |
RGD |
PMID:14718385 PMID:14718385 |
RGD:1641826, RGD:1641826 |
NCBI chr10:91,148,926...91,180,940
|
|
G |
Gdf15 |
growth differentiation factor 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30782979 |
|
NCBI chr16:18,838,436...18,842,022
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:17347304 PMID:12576449 |
RGD:7242556 |
NCBI chr 4:146,865,712...146,869,621
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30782979 |
|
NCBI chr 7:24,169,608...24,249,446
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
associated with Inflammation |
RGD |
PMID:15005009 |
RGD:1626680 |
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
IDA |
associated with Inflammation |
RGD |
PMID:15005009 |
RGD:1626680 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
associated with Leukemia, T-Cell;protein:increased activity:plasma (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17878525 PMID:9110147 |
RGD:11062106 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
associated with colon adenocarcinoma |
RGD |
PMID:28489606 |
RGD:127285673 |
NCBI chr 1:236,408,905...236,468,769
|
|
G |
Lpin1 |
lipin 1 |
|
IEP |
associated with Carcinoma, Hepatocellular;mRNA:increased expression:skeletal muscle |
RGD |
PMID:14718385 |
RGD:1641826 |
NCBI chr 6:45,039,110...45,145,845
|
|
G |
Lta |
lymphotoxin alpha |
susceptibility |
ISO |
associated with Breast Neoplasms;DNA:polymorphism:intron:252G>A (human) |
RGD |
PMID:18953879 |
RGD:8548798 |
NCBI chr20:3,622,291...3,625,852
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
treatment |
IMP |
associated with Pulmonary Arterial Hypertension |
RGD |
PMID:30554141 |
RGD:155791671 |
NCBI chr 5:51,149,524...51,212,012
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
ISO |
associated with Myocardial Infarction |
RGD |
PMID:20371568 |
RGD:6484229 |
NCBI chr18:62,689,798...62,691,685
|
|
G |
Mefv |
MEFV innate immunity regulator, pyrin |
|
ISO |
ClinVar Annotator: match by term: Cachexia |
ClinVar |
PMID:9668175 PMID:10090880 PMID:10612841 PMID:10787450 PMID:10842288 PMID:11464238 PMID:11977178 PMID:15018633 PMID:15024744 PMID:16730661 PMID:17489852 PMID:19253030 PMID:19934083 PMID:20041150 PMID:20534143 PMID:21246368 PMID:21413889 PMID:21978701 PMID:22614345 PMID:22903357 PMID:23505242 PMID:23588594 PMID:23907647 PMID:23981758 PMID:24251727 PMID:24469716 PMID:24929125 PMID:25615955 PMID:25741868 PMID:26078663 PMID:28492532 PMID:29047407 PMID:29543225 PMID:29599418 PMID:31989427 PMID:32312770 PMID:33733382 PMID:34426522 PMID:35098403 More...
|
|
NCBI chr10:11,786,948...11,796,977
|
|
G |
Mstn |
myostatin |
|
IEP |
associated with Carcinoma, Hepatocellular;mRNA:increased expression:skeletal muscle |
RGD |
PMID:18578694 |
RGD:2303552 |
NCBI chr 9:48,452,533...48,458,933
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
ameliorates |
ISO |
associated with Carcinoma, Lewis Lung |
RGD |
PMID:31138662 |
RGD:150530282 |
NCBI chr 8:127,952,161...127,956,230
|
|
G |
Parl |
presenilin associated, rhomboid-like |
|
ISO |
|
RGD |
PMID:16839884 |
RGD:12902627 |
NCBI chr11:80,594,059...80,620,506
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive (COPD, MeSH:D029424); RNA:decreased expression:skeletal muscle (human) |
RGD |
PMID:17459894 |
RGD:5683621 |
NCBI chr 7:118,712,261...118,780,723
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17878525 |
|
NCBI chr13:64,714,063...64,722,320
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17878525 |
|
NCBI chr 4:180,188,792...180,199,847
|
|
G |
Slc25a4 |
solute carrier family 25 member 4 |
|
IEP |
associated with hepatocellular carcinoma |
RGD |
PMID:23200745 |
RGD:13782066 |
NCBI chr16:46,072,935...46,076,730
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive (COPD, MeSH:D029424); RNA, protein:decreased expression:skeletal muscle (human) |
RGD |
PMID:17459894 |
RGD:5683621 |
NCBI chr20:17,356,243...17,368,293
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
|
RGD |
PMID:2054795 |
RGD:7394820 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism associated with hepatocellular carcinoma;mRNA:altered expression:skeletal muscle tissue, adipose tissue (rat) |
CTD RGD |
PMID:17878525 PMID:16077938 |
RGD:1624190 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP ISO |
associated with Carcinoma, Hepatocellular;protein, mRNA:increased expression:skeletal muscle, adipose tissue CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:18801959 PMID:16077938 |
RGD:1624190 |
NCBI chr 4:159,837,119...159,849,817
|
|
G |
Zfp36 |
zinc finger protein 36 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12756304 PMID:15944294 |
|
NCBI chr 1:92,796,628...92,799,108
|
|
|
G |
Mgme1 |
mitochondrial genome maintenance exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23313956 |
|
NCBI chr 3:131,640,770...131,649,933
|
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17194745 |
|
NCBI chr20:9,128,056...9,184,312
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 2:245,518,693...245,542,864
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322899 |
|
NCBI chr10:91,410,129...91,430,246
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12860835 |
|
NCBI chr11:91,226,524...91,240,244
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 PMID:30813227 PMID:31306034 PMID:36029422 |
|
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322899 |
|
NCBI chr17:70,669,684...70,717,935
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:78,986,252...79,022,638
|
|
G |
Anxa5 |
annexin A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 2:121,242,133...121,272,935
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr14:41,849,638...42,232,930
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr11:37,506,207...37,724,351
|
|
G |
Arhgef12 |
Rho guanine nucleotide exchange factor 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:52,247,047...52,373,158
|
|
G |
Asip |
agouti signaling protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:37769864 |
|
NCBI chr 3:163,933,768...164,021,377
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:179,695,662...179,777,973
|
|
G |
Calm1 |
calmodulin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 6:125,217,191...125,227,855
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:46,606,538...46,639,616
|
|
G |
Cavin1 |
caveolae associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:85,884,100...85,896,136
|
|
G |
Cd36 |
CD36 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
G |
Clic4 |
chloride intracellular channel 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 5:147,453,702...147,513,455
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20107430 |
|
NCBI chr 5:53,204,867...53,230,396
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:59,366,086...59,501,591
|
|
G |
Cpe |
carboxypeptidase E |
|
ISO |
associated with kidney transplant;DNA:SNP:CDS (rs1946816) (human) |
RGD |
PMID:26406335 |
RGD:405650673 |
NCBI chr16:25,030,276...25,142,231
|
|
G |
Ctsd |
cathepsin D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 1:206,956,945...206,968,821
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19997080 |
|
NCBI chr 7:115,762,662...115,771,832
|
|
G |
Ddo |
D-aspartate oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16525061 |
|
NCBI chr20:44,090,823...44,109,962
|
|
G |
Dnah11 |
dynein, axonemal, heavy chain 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 6:138,839,175...139,155,554
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20375926 |
|
NCBI chr 8:58,605,403...58,669,339
|
|
G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr19:538,207...561,110
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30971429 |
|
NCBI chr 4:76,624,399...76,687,362
|
|
G |
Fbln2 |
fibulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:123,704,289...123,763,857
|
|
G |
Fbxo21 |
F-box protein 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr12:38,570,878...38,605,133
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 6:16,654,572...16,694,628
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr18:30,937,670...31,023,786
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29220483 |
|
NCBI chr 5:115,514,573...115,901,713
|
|
G |
Fstl1 |
follistatin-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr11:62,895,391...62,948,581
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322899 |
|
NCBI chr19:31,456,749...31,865,011
|
|
G |
Gdf15 |
growth differentiation factor 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr16:18,838,436...18,842,022
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17372281 |
|
NCBI chr10:91,727,883...91,729,860
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16493877 PMID:33301842 |
|
NCBI chr 4:146,865,712...146,869,621
|
|
G |
Gnb3 |
G protein subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16141801 |
|
NCBI chr 4:157,639,468...157,645,171
|
|
G |
Gpr55 |
G protein-coupled receptor 55 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30148676 |
|
NCBI chr 9:94,037,748...94,081,426
|
|
G |
Grb14 |
growth factor receptor bound protein 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 3:49,568,210...49,683,805
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 3:38,982,605...39,035,849
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27071101 |
|
NCBI chr10:86,190,289...86,191,524
|
|
G |
Hdhd2 |
haloacid dehalogenase-like hydrolase domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr18:70,488,315...70,526,471
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19434072 PMID:19997080 |
|
NCBI chr X:115,453,190...115,682,325
|
|
G |
Hycc2 |
hyccin PI4KA lipid kinase complex subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 9:60,056,883...60,129,176
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 |
|
NCBI chr16:74,133,259...74,145,328
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 9:74,452,371...74,464,953
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20376352 |
|
NCBI chr 2:96,142,523...96,186,282
|
|
G |
Insig2 |
insulin induced gene 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18195716 PMID:20373477 |
|
NCBI chr13:32,472,390...32,500,139
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 1:144,088,788...144,178,989
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27605626 |
|
NCBI chr15:302,480...1,007,675
|
|
G |
Kcnmb1 |
potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27288421 |
|
NCBI chr10:19,062,014...19,119,005
|
|
G |
Large1 |
LARGE xylosyl- and glucuronyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr19:11,603,129...12,048,930
|
|
G |
Lbp |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 3:146,953,889...146,981,032
|
|
G |
Lep |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:15070752 PMID:15809509 PMID:17502770 PMID:19716478 PMID:21561152 PMID:25086370 PMID:27472835 PMID:29967158 PMID:38906502 More...
|
|
NCBI chr 4:58,626,529...58,640,663
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15809509 PMID:29143802 PMID:29988851 PMID:36066211 PMID:36880193 PMID:39059604 More...
|
|
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr13:105,825,630...105,896,366
|
|
G |
Map4 |
microtubule-associated protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:109,925,233...110,064,370
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 3:162,679,020...162,707,167
|
|
G |
Mapt |
microtubule-associated protein tau |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29203278 |
|
NCBI chr10:89,638,618...89,736,108
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:96,429,057...96,540,244
|
|
G |
Mest |
mesoderm specific transcript |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:59,354,445...59,364,919
|
|
G |
Metrnl |
meteorin-like, glial cell differentiation regulator |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30213948 |
|
NCBI chr10:106,963,880...106,977,875
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26996129 |
|
NCBI chr10:71,902,600...71,902,691
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:4,581,785...4,591,687
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25322899 |
|
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mprip |
myosin phosphatase Rho interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:44,953,472...45,073,388
|
|
G |
Mrtfa |
myocardin related transcription factor A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33779332 |
|
NCBI chr 7:112,544,305...112,714,418
|
|
G |
Myo10 |
myosin X |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 2:77,831,532...78,036,137
|
|
G |
Myo1b |
myosin Ib |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 9:49,690,043...49,852,373
|
|
G |
Ndc1 |
NDC1 transmembrane nucleoporin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 5:122,155,992...122,202,295
|
|
G |
Ndufb9 |
NADH:ubiquinone oxidoreductase subunit B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 7:90,480,948...90,487,367
|
|
G |
Nek7 |
NIMA-related kinase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr13:52,573,730...52,700,869
|
|
G |
Nid1 |
nidogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr17:86,085,133...86,158,272
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 2:60,865,483...60,933,432
|
|
G |
Nus1 |
NUS1 dehydrodolichyl diphosphate synthase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33812996 |
|
NCBI chr20:31,811,817...31,838,562
|
|
G |
Osbpl8 |
oxysterol binding protein-like 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 7:46,596,944...46,749,888
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18562099 |
|
NCBI chr 3:117,782,650...117,783,490
|
|
G |
Pakap |
paralemmin A kinase anchor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 5:72,536,986...72,648,524 NCBI chr 5:72,313,646...72,450,645
|
|
G |
Palld |
palladin, cytoskeletal associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr16:33,238,943...33,632,236
|
|
G |
Pcyox1 |
prenylcysteine oxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:120,389,545...120,400,382
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 2:117,103,643...117,177,411
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:4367732 PMID:6143199 |
|
NCBI chr 6:32,659,137...32,665,175
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20176998 |
|
NCBI chr20:6,300,527...6,365,707
|
|
G |
Prkd3 |
protein kinase D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 6:21,784,665...21,860,600
|
|
G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr X:108,920,663...108,942,713
|
|
G |
Pycard |
PYD and CARD domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24508291 |
|
NCBI chr 1:192,032,124...192,033,419
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:86,689,148...86,690,956
|
|
G |
Rfng |
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:106,047,221...106,050,331
|
|
G |
Rpl28 |
ribosomal protein L28 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 1:69,052,148...69,054,735
|
|
G |
Rps28 |
ribosomal protein S28 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 7:14,607,801...14,609,170
|
|
G |
Rps8 |
ribosomal protein S8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 5:130,630,362...130,632,932
|
|
G |
Ryk |
receptor-like tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:112,298,158...112,370,912
|
|
G |
Scd |
stearoyl-CoA desaturase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21661758 |
|
NCBI chr 1:253,218,968...253,232,101
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 1:243,169,171...243,182,231
|
|
G |
Sepsecs |
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr14:58,311,484...58,341,745
|
|
G |
Serpinb6a |
serpin family B member 6A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr17:30,871,468...30,989,703
|
|
G |
Sestd1 |
SEC14 and spectrin domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 3:62,123,590...62,220,759
|
|
G |
Setbp1 |
SET binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr18:74,465,616...74,827,455
|
|
G |
Sipa1l1 |
signal-induced proliferation-associated 1 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 6:107,570,569...107,849,613
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
|
ISO |
associated with kidney transplant;DNA:SNP:CDS (rs6347) (human) |
RGD |
PMID:26406335 |
RGD:405650673 |
NCBI chr 1:31,537,990...31,578,962
|
|
G |
Slu7 |
SLU7 homolog, splicing factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:27,908,325...27,923,784
|
|
G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr16:46,435,220...46,748,743
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr10:39,516,394...39,538,252
|
|
G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr14:103,841,713...104,016,900
|
|
G |
Sri |
sorcin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33930463 |
|
NCBI chr 4:26,928,338...26,952,980
|
|
G |
Stim2 |
stromal interaction molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr14:56,878,428...57,004,405
|
|
G |
Sts |
steroid sulfatase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24497646 |
|
NCBI chr X:46,102,524...46,110,868
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
|
RGD |
PMID:21467195 |
RGD:5147668 |
NCBI chr 4:116,478,617...116,647,492
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:39265716 |
|
NCBI chr 1:29,637,213...29,659,561
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20521320 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tpm4 |
tropomyosin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr16:17,718,442...17,732,483
|
|
G |
Tsen2 |
tRNA splicing endonuclease subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 4:148,602,805...148,638,219
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
RGD |
PMID:30905785 PMID:30905785 |
RGD:14402029, RGD:14402029 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr17:81,577,261...81,585,746
|
|
G |
Vps13d |
vacuolar protein sorting 13 homolog D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 5:162,113,732...162,339,121
|
|
G |
Zdhhc2 |
zinc finger DHHC-type palmitoyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr16:51,808,465...51,878,060
|
|
G |
Zwilch |
zwilch kinetochore protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19030233 |
|
NCBI chr 8:64,638,401...64,670,911
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33007385 |
|
NCBI chr10:91,410,129...91,430,246
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33007385 |
|
NCBI chr X:30,293,597...30,340,961
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18230824 |
|
NCBI chr11:91,226,524...91,240,244
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26526685 |
|
NCBI chr20:13,315,848...13,333,386
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34848246 |
|
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Alpk1 |
alpha-kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27542954 |
|
NCBI chr 2:218,801,425...218,924,013
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24431404 PMID:35362542 |
|
NCBI chr18:26,138,382...26,196,021
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26568842 |
|
NCBI chr20:49,380,835...49,471,826
|
|
G |
Atg7 |
autophagy related 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26568842 |
|
NCBI chr 4:149,390,000...149,597,534
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38761876 |
|
NCBI chr16:76,654,725...76,726,092
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28411859 |
|
NCBI chr18:28,609,558...28,611,409
|
|
G |
Cln6 |
CLN6, transmembrane ER protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23789114 |
|
NCBI chr 8:63,303,356...63,318,360
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31570772 PMID:32365865 |
|
NCBI chr 5:53,204,867...53,230,396
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:27611972 PMID:30102254 |
|
NCBI chr 5:153,408,968...153,435,092
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26070417 PMID:29908986 |
|
NCBI chr 7:130,977,561...131,006,627
|
|
G |
Crh |
corticotropin releasing hormone |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8986836 |
|
NCBI chr 2:104,059,184...104,061,048
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:38348709 |
|
NCBI chr10:38,887,692...38,889,673
|
|
G |
Epo |
erythropoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8260696 |
|
NCBI chr12:19,204,258...19,207,948
|
|
G |
Fst |
follistatin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33034787 |
|
NCBI chr 2:47,856,345...47,863,670
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7711889 |
|
NCBI chr10:91,727,883...91,729,860
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24431404 |
|
NCBI chr15:41,972,482...41,976,690
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34973135 |
|
NCBI chr18:29,770,637...29,789,850
|
|
G |
Igf2bp1 |
insulin-like growth factor 2 mRNA binding protein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:38866309 |
|
NCBI chr10:80,908,300...80,951,097
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:24314293 PMID:27580383 |
|
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24314293 |
|
NCBI chr10:38,272,003...38,277,549
|
|
G |
Ins1 |
insulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29682576 PMID:34352274 |
|
NCBI chr 1:261,186,119...261,186,686
|
|
G |
Ins2 |
insulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22940631 PMID:29211853 |
|
NCBI chr 1:207,272,738...207,421,998
|
|
G |
Lep |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27417254 |
|
NCBI chr 4:58,626,529...58,640,663
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23291613 |
|
NCBI chr14:83,354,602...83,364,053
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31174552 |
|
NCBI chr 7:124,706,246...124,867,234
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24587916 |
|
NCBI chr 8:110,999,948...111,022,795
|
|
G |
Mapt |
microtubule-associated protein tau |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24556215 |
|
NCBI chr10:89,638,618...89,736,108
|
|
G |
Mt1 |
metallothionein 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24163136 |
|
NCBI chr19:10,831,959...10,832,975
|
|
G |
Nppc |
natriuretic peptide C |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:37352108 |
|
NCBI chr 9:94,767,986...94,772,186
|
|
G |
Npy |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25825358 |
|
NCBI chr 4:80,212,111...80,219,310
|
|
G |
Otud7b |
OTU deubiquitinase 7B |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:36639017 |
|
NCBI chr 2:183,661,955...183,722,584
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18562099 |
|
NCBI chr 3:117,782,650...117,783,490
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1459535 PMID:11193135 |
|
NCBI chr 6:32,659,137...32,665,175
|
|
G |
Sirt4 |
sirtuin 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:35134463 |
|
NCBI chr12:41,125,533...41,139,440
|
|
G |
Snca |
synuclein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32278788 |
|
NCBI chr 4:91,026,474...91,127,444
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24163136 PMID:29434186 |
|
NCBI chr11:42,942,742...42,948,399
|
|
G |
Tes |
testin LIM domain protein |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:39237074 |
|
NCBI chr 4:45,365,304...45,403,829
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28726298 |
|
NCBI chr16:53,554,916...53,572,321
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31442584 |
|
NCBI chr 5:85,161,247...85,174,882
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22556341 |
|
NCBI chr X:109,006,410...109,066,389
|
|